🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the safety, tolerability, and immun...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2021-07-08
Trial ID
NCT04927585
Treatments Being Tested
This international, multi-centre, double-blind vaccine study is a three-arm...
Status
Completed
Location
MRC/UVRI and LSHTM Uganda Research Unit
Start Date
2020-12-15
Trial ID
NCT04066881
Treatments Being Tested
Therapeutic HIV vaccines are designed to control HIV infection by boosting ...
Status
Completed
Location
UCLA CARE Center CRS
Start Date
2011-03
Trial ID
NCT01266616
Treatments Being Tested
A phase Ib partially blinded pilot study to evaluate the safety and immunol...
Status
Completed
Location
University of Pennsylvania. Clinical Trials Unit
Start Date
2008-09
Trial ID
NCT00775424
Treatments Being Tested
The purpose of this study is to evaluate whether the HIV vaccine VRC-HIVDNA...
Status
Completed
Location
Ucsd, Avrc Crs
Start Date
TBD
Trial ID
NCT00125099
Treatments Being Tested
The central premise of our program is that durable control of HIV in the ab...
Status
Completed
Location
University of California, Los Angeles
Start Date
2018-08-01
Trial ID
NCT03606213
Treatments Being Tested
The purpose of this study is to evaluate the safety of and immune response ...
Status
Completed
Location
Rockville Vaccine Assessment Clinic (RVAC)
Start Date
2010-02
Trial ID
NCT01260727
Treatments Being Tested
The purpose of the study is to determine the safety of and immune response ...
Status
Completed
Location
San Francisco Vaccine and Prevention CRS
Start Date
2006-01
Trial ID
NCT00141024
Treatments Being Tested
The purpose of the study is to evaluate the safety, tolerability, and immun...
Status
Not Yet Recruiting
Location
Brigham and Women's Hospital
Start Date
2026-09-01
Trial ID
NCT07675629
This study evaluated the safety, immunogenicity, and preliminary assessment...
Status
Completed
Location
Alabama CRS
Start Date
2019-03-26
Trial ID
NCT03560258